Skip to main content
Figure 2 | BMC Cancer

Figure 2

From: Frequent promoter hypermethylation of RASSF1A and CASP8 in neuroblastoma

Figure 2

Promoter methylation analysis of RASSF1A (A), NORE1A (B), BLU (C) and CASP8 (D) in neuroblastic tumors (B, C and D) and cell lines (A), determined by MSP and visualized in 2.5% agarose gels stained with 0.1 μg/ml ethidium bromide. U/M: unmethylated/methylated; M: 1 Kb Plus DNA Ladder (Invitrogen™ Life and Technologies, Carlsbad, CA, USA); B: DNA obtained from blood of a normal donor; IMD (in vitro methylated DNA): positive control, CpGenome™ Universal Methylated DNA (Chemicon International, Inc., Temecula, CA, USA);-: water (no DNA negative control). A) 2: SH-SY5Y; 3: SK-N-SH; 4: SK-N-MC; 5: IMR-32; 6: MHH-NB-11; 7: SK-N-Be(2); 8: SK-N-DZ; 9: BE(2)C. B), C), and D) Numbers on top of each well correspond to DNA from different neuroblastic tumors analyzed.

Back to article page